247 related articles for article (PubMed ID: 25452756)
1. Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art.
Bonatti F; Reina M; Neri TM; Martorana D
Front Immunol; 2014; 5():577. PubMed ID: 25452756
[TBL] [Abstract][Full Text] [Related]
2. [Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: advances in pathogenesis and treatment].
Silva F; Cisternas M
Rev Med Chil; 2013 Jun; 141(6):765-73. PubMed ID: 24121580
[TBL] [Abstract][Full Text] [Related]
3. Familial Association of Granulomatosis With Polyangiitis: A Case-Based Review of Literature.
Farrukh L; Mumtaz A; Sami F; Faraz M; Ngo KR
Cureus; 2023 Jun; 15(6):e40786. PubMed ID: 37485186
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
[TBL] [Abstract][Full Text] [Related]
5. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H; Lee SM; Manno RL; Seo P; Geetha D
Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
[TBL] [Abstract][Full Text] [Related]
8. Current therapies for ANCA-associated vasculitis.
Lally L; Spiera R
Annu Rev Med; 2015; 66():227-40. PubMed ID: 25341007
[TBL] [Abstract][Full Text] [Related]
9. Immunopathology of ANCA-associated vasculitis.
Csernok E; Müller A; Gross WL
Intern Med; 1999 Oct; 38(10):759-65. PubMed ID: 10526937
[TBL] [Abstract][Full Text] [Related]
10. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 1. Systemic aspects, pathogenesis and clinical aspects].
Gross WL; Reinhold-Keller E
Z Rheumatol; 1995; 54(5):279-90. PubMed ID: 8578884
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome).
Mouthon L; Dunogue B; Guillevin L
J Autoimmun; 2014; 48-49():99-103. PubMed ID: 24530234
[TBL] [Abstract][Full Text] [Related]
13. The role of rituximab in the treatment of ANCA-associated vasculitides (AAV).
Daikeler T; Kistler AD; Martin PY; Vogt B; Huynh-Do U
Swiss Med Wkly; 2015; 145():w14103. PubMed ID: 25658140
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
[TBL] [Abstract][Full Text] [Related]
15. Granulomatous Vasculitis.
Sharma A; Dogra S; Sharma K
Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
[TBL] [Abstract][Full Text] [Related]
16. Tobacco differentially affects the clinical-biological phenotypes of ANCA-associated vasculitides.
Benarous L; Terrier B; Puéchal X; Dunogué B; Cohen P; Le Jeunne C; Mouthon L; Guillevin L;
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-116-21. PubMed ID: 26016761
[TBL] [Abstract][Full Text] [Related]
17. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?
Mahr AD
APMIS Suppl; 2009 Jun; (127):41-7. PubMed ID: 19515139
[TBL] [Abstract][Full Text] [Related]
19. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany.
Herlyn K; Buckert F; Gross WL; Reinhold-Keller E
Rheumatology (Oxford); 2014 May; 53(5):882-9. PubMed ID: 24425780
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
